These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 37454492
1. CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K/AKT/HIF-1α signaling. Cao J, Cao R, Liu Y, Dai T. Pathol Res Pract; 2023 Aug; 248():154634. PubMed ID: 37454492 [Abstract] [Full Text] [Related]
2. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer. Shao Z, Ma X, Zhang Y, Sun Y, Lv W, He K, Xia R, Wang P, Gao X. Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526 [Abstract] [Full Text] [Related]
3. SPAG4 enhances mitochondrial respiration and aerobic glycolysis in colorectal cancer cells by activating the PI3K/Akt signaling pathway. Zhou J, Sun H, Zhou H, Liu Y. J Biochem Mol Toxicol; 2024 Nov; 38(11):e70009. PubMed ID: 39410830 [Abstract] [Full Text] [Related]
4. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y, Hu S, Chen Y, Zhang X, Gao H, Tian J, Chen J. Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [Abstract] [Full Text] [Related]
5. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway. Guo M, Liu M, Li W, Wang C, Zhang L, Zhang H. J Cancer Res Clin Oncol; 2024 Mar 25; 150(3):155. PubMed ID: 38526702 [Abstract] [Full Text] [Related]
6. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway. Wu C, Qiu S, Liu P, Ge Y, Gao X. J Ethnopharmacol; 2018 Jan 30; 211():89-100. PubMed ID: 28962890 [Abstract] [Full Text] [Related]
7. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer. Song H, Wu T, Xie D, Li D, Hua K, Hu J, Fang L. Cell Physiol Biochem; 2018 Jan 30; 48(5):1968-1982. PubMed ID: 30092563 [Abstract] [Full Text] [Related]
9. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling. Cheng W, Liu D, Guo M, Li H, Wang Q. Drug Dev Res; 2022 Aug 30; 83(5):1138-1151. PubMed ID: 35426453 [Abstract] [Full Text] [Related]
12. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway. Gong T, Cui L, Wang H, Wang H, Han N. J Transl Med; 2018 Jun 14; 16(1):164. PubMed ID: 29898734 [Abstract] [Full Text] [Related]
13. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer. Ding L, Xie Z. Exp Mol Pathol; 2021 Dec 14; 123():104704. PubMed ID: 34624276 [Abstract] [Full Text] [Related]
15. JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway. Li J, Zhang X, Liu X, Ma X, Wang Y, Liu Y. Expert Rev Anticancer Ther; 2024 Oct 14; 24(10):1029-1040. PubMed ID: 39254227 [Abstract] [Full Text] [Related]